EVH · NYSE
Evolent Health (EVH) Stock Price & Fundamentals
Evolent Health (EVH) closed at $370.51 on Oct 9, 2026, down 0.07% from the previous close of $370.77.
Share price, past year
1Y +16.54%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $370.51 |
| Sep 30, 2026 | $371.84 |
| Aug 31, 2026 | $372.07 |
| Jul 31, 2026 | $376.57 |
| Jun 30, 2026 | $370.91 |
| May 29, 2026 | $363.28 |
| Apr 30, 2026 | $352.01 |
| Mar 31, 2026 | $352.46 |
| Feb 27, 2026 | $362.48 |
| Jan 30, 2026 | $366.07 |
| Dec 31, 2025 | $334.46 |
| Nov 28, 2025 | $318.66 |
| Oct 31, 2025 | $324.11 |
Key statistics
- Market cap
- $41.89B
- P/E (TTM)
- —
- EPS (TTM)
- −$4.57
- Revenue (TTM)
- $2.10B
- Net income (TTM)
- −$504.99M
- Shares outstanding
- 113.1M
- Dividend yield
- —
- 52-week range
- $316.33 – $382.58
Evolent Health's market cap is $41.89B, based on a share price of $370.51 and 113.1M shares outstanding as of Aug 1, 2026.
Financials
Evolent Health reported revenue of $1.88B for fiscal 2025, down 26.56% from fiscal 2024.
Evolent Health reported a net loss of $534.51M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.88B | −26.6% | −$534.51M | −28.5% | −$5.07 | — |
| FY2024ended Dec 31, 2024 | $2.55B | +30.1% | −$61.62M | −2.4% | −$0.81 | — |
| FY2023ended Dec 31, 2023 | $1.96B | +45.3% | −$113.04M | −5.8% | −$1.28 | — |
| FY2022ended Dec 31, 2022 | $1.35B | +48.9% | −$19.16M | −1.4% | −$0.20 | — |
| FY2021ended Dec 31, 2021 | $907.96M | −1.8% | −$37.60M | −4.1% | −$0.44 | — |
| FY2020ended Dec 31, 2020 | $924.64M | +34.6% | −$334.25M | −36.2% | −$3.94 | — |
| FY2019ended Dec 31, 2019 | $687.12M | +9.6% | −$301.97M | −44.0% | −$3.67 | −$78.18M |
| FY2018ended Dec 31, 2018 | $627.06M | +44.2% | −$52.66M | −8.4% | −$0.68 | −$60.20M |
| FY2017ended Dec 31, 2017 | $434.95M | +71.1% | −$60.67M | −14.0% | −$0.94 | −$55.81M |
| FY2016ended Dec 31, 2016 | $254.19M | — | −$159.74M | −62.8% | −$3.55 | −$51.04M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $652.52M | −$28.36M | −$0.25 |
| Q1 FY2026ended Mar 31, 2026 | $496.25M | −$26.63M | −$0.24 |
| Q4 FY2025ended Dec 31, 2025 | $468.72M | −$429.13M | −$3.84 |
| Q3 FY2025ended Sep 30, 2025 | $479.53M | −$20.86M | −$0.24 |
| Q2 FY2025ended Jun 30, 2025 | $444.33M | −$19.90M | −$0.44 |
| Q1 FY2025ended Mar 31, 2025 | $483.65M | −$64.62M | −$0.63 |
| Q4 FY2024ended Dec 31, 2024 | $646.54M | −$22.80M | −$0.27 |
| Q3 FY2024ended Sep 30, 2024 | $621.40M | −$23.14M | −$0.27 |
Company profile
- Name
- Evolent Health, Inc.
- Ticker
- EVH
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-Management Services
- Headquarters
- 1812 North Moore St, Suite 1705, Arlington, VA 22209
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001628908
Recent SEC filings
- Aug 6, 2026
- Aug 6, 2026
- Jun 4, 2026
- May 7, 2026
- May 7, 2026
- Feb 25, 2026
- Feb 24, 2026
- Dec 8, 2025
Frequently asked questions
What is Evolent Health's stock price?
Evolent Health (EVH) closed at $370.51 on Oct 9, 2026, down 0.07% from the previous close of $370.77.
What is Evolent Health's market cap?
Evolent Health's market cap is $41.89B, based on a share price of $370.51 and 113.1M shares outstanding as of Aug 1, 2026.
How much revenue does Evolent Health make?
Evolent Health reported revenue of $1.88B for fiscal 2025, down 26.56% from fiscal 2024.
Does Evolent Health pay a dividend?
Evolent Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Evolent Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures